Publication Name	World Journal of Hepatology
Manuscript ID	98422
Country	Argentina

Received	2024-06-25 23:35
Peer-Review Started	2024-06-25 23:35
To Make the First Decision
Return for Revision	2024-08-23 21:50
Revised	2024-09-02 23:05
Second Decision	2024-10-11 02:34
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-11 09:05
Articles in Press	2024-10-11 09:05
Publication Fee Transferred
Edit the Manuscript by Language Editor	2024-10-21 00:00
Typeset the Manuscript	2024-10-28 00:25
Publish the Manuscript Online	2024-11-06 09:51

ISSN	1948-5182 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Autoimmune hepatitis: Towards a personalized treatment
Manuscript Source	Invited Manuscript
All Author List	Alejandro Costaguta, Guillermo Costaguta and Fernando Álvarez
ORCID	Author(s) ORCID Number Alejandro Costaguta http://orcid.org/0000-0002-3607-2212 Guillermo Costaguta http://orcid.org/0000-0002-0468-5321 Fernando Álvarez http://orcid.org/0000-0002-0534-5142
Funding Agency and Grant Number
Corresponding Author	Alejandro Costaguta, MD, Chief Physician, Department of Hepatology and Liver Transplant Unit, Sanatorio de Niños de Rosario, Alvear 863, CP 2000, Rosario 2000, Santa Fe, Argentina. alejandro.costaguta@gmail.com
Key Words	Novel therapies; Immunosuppressors; Treatment tailoring; Personalization; Special populations
Core Tip	Autoimmune hepatitis is a serious condition that affects both adults and children, with a poor prognosis if left untreated. Historically, treatment has involved high-dose steroids to induce remission and maintenance therapy with azathioprine, which achieves remission in 80% of cases but requires alternative therapies for the remaining 20%. While there have been advancements in immunosuppressive therapies for other diseases, treatment protocols for autoimmune hepatitis have remained largely unchanged. In this article, we will explore alternative treatment options for patients for whom the standard protocol is not suitable.
Publish Date	2024-11-06 09:51
Citation	<p>Costaguta A, Costaguta G, Álvarez F. Autoimmune hepatitis: Towards a personalized treatment. <i>World J Hepatol</i> 2024; 16(11): 1225-1242</p>
URL	https://www.wjgnet.com/1948-5182/full/v16/i11/1225.htm
DOI	https://dx.doi.org/10.4254/wjh.v16.i11.1225

Full Article (PDF)	WJH-16-1225-with-cover.pdf
Manuscript File	98422_Auto_Edited_010100.docx
Answering Reviewers	98422-answering-reviewers.pdf
Audio Core Tip	98422-audio.m4a
Conflict-of-Interest Disclosure Form	98422-conflict-of-interest-statement.pdf
Copyright License Agreement	98422-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate	98422-non-native-speakers.pdf
Peer-review Report	98422-peer-reviews.pdf
Scientific Misconduct Check	98422-scientific-misconduct-check.png
Scientific Editor Work List	98422-scientific-editor-work-list.pdf
CrossCheck Report	98422-crosscheck-report.png
CrossCheck Report	98422-crosscheck-report.pdf